Cyclacel Pharmaceuticals, Inc.
(NASDAQ : CYCC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.05%191.461.2%$560.96m
GILDGilead Sciences, Inc.
0.25%71.100.9%$497.01m
BIIBBiogen Inc.
-1.02%315.821.3%$443.97m
CELGCelgene Corporation
-0.50%69.891.2%$416.33m
ILMNIllumina, Inc.
-0.38%310.003.5%$396.78m
REGNRegeneron Pharmaceuticals, Inc.
-1.23%337.892.6%$278.31m
VRTXVertex Pharmaceuticals Incorporated
-3.01%165.191.9%$263.19m
ALXNAlexion Pharmaceuticals, Inc.
-1.37%116.902.0%$196.35m
AAgilent Technologies, Inc.
-0.67%63.911.5%$167.02m
EXASExact Sciences Corporation
-1.46%68.4025.3%$147.48m
LGNDLigand Pharmaceuticals Incorporated
0.36%148.9723.3%$144.13m
SRPTSarepta Therapeutics, Inc.
-3.86%112.2616.4%$128.42m
ECYTEndocyte, Inc.
-0.11%23.562.0%$120.16m
INCYIncyte Corporation
0.63%64.132.5%$113.10m
NKTRNektar Therapeutics
2.41%38.255.6%$108.41m

Company Profile

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. The company builds a diversified biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products includes CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.